Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 9/10

vs
industry
vs
history
Cash to Debt No Debt
ATRI's Cash to Debt is ranked higher than
94% of the 314 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.03 vs. ATRI: No Debt )
ATRI' s 10-Year Cash to Debt Range
Min: 0.01   Max: No Debt
Current: No Debt

Equity to Asset 0.87
ATRI's Equity to Asset is ranked higher than
95% of the 310 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 0.56 vs. ATRI: 0.87 )
ATRI' s 10-Year Equity to Asset Range
Min: 0.61   Max: 0.88
Current: 0.87

0.61
0.88
Interest Coverage No Debt
ATRI's Interest Coverage is ranked higher than
82% of the 174 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 32.94 vs. ATRI: No Debt )
ATRI' s 10-Year Interest Coverage Range
Min: 4   Max: 9999.99
Current: No Debt

4
9999.99
F-Score: 6
Z-Score: 20.42
M-Score: -2.23
WACC vs ROIC
12.24%
24.32%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 7/10

vs
industry
vs
history
Operating margin (%) 29.00
ATRI's Operating margin (%) is ranked higher than
97% of the 312 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 10.17 vs. ATRI: 29.00 )
ATRI' s 10-Year Operating margin (%) Range
Min: 1.65   Max: 32.43
Current: 29

1.65
32.43
Net-margin (%) 19.76
ATRI's Net-margin (%) is ranked higher than
95% of the 312 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 5.28 vs. ATRI: 19.76 )
ATRI' s 10-Year Net-margin (%) Range
Min: 4.35   Max: 56.77
Current: 19.76

4.35
56.77
ROE (%) 18.41
ATRI's ROE (%) is ranked higher than
92% of the 299 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 8.60 vs. ATRI: 18.41 )
ATRI' s 10-Year ROE (%) Range
Min: 4.43   Max: 40.76
Current: 18.41

4.43
40.76
ROA (%) 15.98
ATRI's ROA (%) is ranked higher than
97% of the 315 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 3.84 vs. ATRI: 15.98 )
ATRI' s 10-Year ROA (%) Range
Min: 3.63   Max: 32.36
Current: 15.98

3.63
32.36
ROC (Joel Greenblatt) (%) 41.84
ATRI's ROC (Joel Greenblatt) (%) is ranked higher than
90% of the 314 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 19.69 vs. ATRI: 41.84 )
ATRI' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: 3.06   Max: 48.1
Current: 41.84

3.06
48.1
Revenue Growth (3Y)(%) 7.10
ATRI's Revenue Growth (3Y)(%) is ranked higher than
81% of the 265 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 5.70 vs. ATRI: 7.10 )
ATRI' s 10-Year Revenue Growth (3Y)(%) Range
Min: 5.4   Max: 56.2
Current: 7.1

5.4
56.2
EBITDA Growth (3Y)(%) 4.40
ATRI's EBITDA Growth (3Y)(%) is ranked higher than
71% of the 236 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 5.00 vs. ATRI: 4.40 )
ATRI' s 10-Year EBITDA Growth (3Y)(%) Range
Min: -40.1   Max: 131.8
Current: 4.4

-40.1
131.8
EPS Growth (3Y)(%) 3.20
ATRI's EPS Growth (3Y)(%) is ranked higher than
71% of the 231 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 8.20 vs. ATRI: 3.20 )
ATRI' s 10-Year EPS Growth (3Y)(%) Range
Min: 3.2   Max: 59.9
Current: 3.2

3.2
59.9
» ATRI's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades

Q1 2014

ATRI Guru Trades in Q1 2014

Jim Simons 15,500 sh (+14.81%)
Joel Greenblatt Sold Out
Chuck Royce 228,259 sh (-6.23%)
» More
Q2 2014

ATRI Guru Trades in Q2 2014

Jim Simons 17,700 sh (+14.19%)
Chuck Royce 218,994 sh (-4.06%)
» More
Q3 2014

ATRI Guru Trades in Q3 2014

Jim Simons 18,500 sh (+4.52%)
Chuck Royce 227,340 sh (+3.81%)
» More
Q4 2014

ATRI Guru Trades in Q4 2014

Jim Simons 18,800 sh (+1.62%)
Chuck Royce 188,385 sh (-17.14%)
Chuck Royce 188,385 sh (-17.14%)
» More
» Details

Insider Trades

Latest Guru Trades with ATRI

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Ratios

vs
industry
vs
history
P/E(ttm) 23.20
ATRI's P/E(ttm) is ranked higher than
89% of the 341 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 57.30 vs. ATRI: 23.20 )
ATRI' s 10-Year P/E(ttm) Range
Min: 8.12   Max: 24.6
Current: 23.2

8.12
24.6
Forward P/E 22.12
ATRI's Forward P/E is ranked higher than
77% of the 341 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 60.61 vs. ATRI: 22.12 )
N/A
PE(NRI) 23.20
ATRI's PE(NRI) is ranked higher than
89% of the 341 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 58.80 vs. ATRI: 23.20 )
ATRI' s 10-Year PE(NRI) Range
Min: 8.12   Max: 24.6
Current: 23.2

8.12
24.6
P/B 4.20
ATRI's P/B is ranked higher than
58% of the 341 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.00 vs. ATRI: 4.20 )
ATRI' s 10-Year P/B Range
Min: 1.23   Max: 4.42
Current: 4.2

1.23
4.42
P/S 4.59
ATRI's P/S is ranked lower than
58% of the 341 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 3.21 vs. ATRI: 4.59 )
ATRI' s 10-Year P/S Range
Min: 1.2   Max: 4.86
Current: 4.59

1.2
4.86
PFCF 34.70
ATRI's PFCF is ranked higher than
74% of the 341 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 91.20 vs. ATRI: 34.70 )
ATRI' s 10-Year PFCF Range
Min: 7.41   Max: 429.32
Current: 34.7

7.41
429.32
POCF 20.67
ATRI's POCF is ranked higher than
81% of the 341 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 29.48 vs. ATRI: 20.67 )
ATRI' s 10-Year POCF Range
Min: 5.97   Max: 21.91
Current: 20.67

5.97
21.91
EV-to-EBIT 14.41
ATRI's EV-to-EBIT is ranked higher than
93% of the 341 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 36.88 vs. ATRI: 14.41 )
ATRI' s 10-Year EV-to-EBIT Range
Min: 4.6   Max: 16.1
Current: 14.41

4.6
16.1
PEG 2.97
ATRI's PEG is ranked higher than
91% of the 341 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 0.00 vs. ATRI: 2.97 )
ATRI' s 10-Year PEG Range
Min: 0.2   Max: 6.3
Current: 2.97

0.2
6.3
Shiller P/E 26.80
ATRI's Shiller P/E is ranked higher than
91% of the 341 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 0.00 vs. ATRI: 26.80 )
ATRI' s 10-Year Shiller P/E Range
Min: 11.4   Max: 30.02
Current: 26.8

11.4
30.02
Current Ratio 7.46
ATRI's Current Ratio is ranked higher than
96% of the 313 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.55 vs. ATRI: 7.46 )
ATRI' s 10-Year Current Ratio Range
Min: 1.37   Max: 9.65
Current: 7.46

1.37
9.65
Quick Ratio 4.64
ATRI's Quick Ratio is ranked higher than
92% of the 313 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.68 vs. ATRI: 4.64 )
ATRI' s 10-Year Quick Ratio Range
Min: 1.19   Max: 6.84
Current: 4.64

1.19
6.84
Days Inventory 137.66
ATRI's Days Inventory is ranked higher than
71% of the 341 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 137.40 vs. ATRI: 137.66 )
ATRI' s 10-Year Days Inventory Range
Min: 74.75   Max: 140.27
Current: 137.66

74.75
140.27
Days Sales Outstanding 43.98
ATRI's Days Sales Outstanding is ranked higher than
93% of the 341 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 70.03 vs. ATRI: 43.98 )
ATRI' s 10-Year Days Sales Outstanding Range
Min: 34.8   Max: 433.63
Current: 43.98

34.8
433.63

Dividend & Buy Back

vs
industry
vs
history
Dividend Yield 0.88
ATRI's Dividend Yield is ranked lower than
66% of the 154 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.34 vs. ATRI: 0.88 )
ATRI' s 10-Year Dividend Yield Range
Min: 0.67   Max: 1.74
Current: 0.88

0.67
1.74
Dividend Payout 0.20
ATRI's Dividend Payout is ranked higher than
94% of the 341 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 0.00 vs. ATRI: 0.20 )
ATRI' s 10-Year Dividend Payout Range
Min: 0.09   Max: 0.49
Current: 0.2

0.09
0.49
Dividend growth (3y) 15.20
ATRI's Dividend growth (3y) is ranked higher than
84% of the 132 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 9.10 vs. ATRI: 15.20 )
ATRI' s 10-Year Dividend growth (3y) Range
Min: 0   Max: 45.5
Current: 15.2

0
45.5
Yield on cost (5-Year) 1.88
ATRI's Yield on cost (5-Year) is ranked higher than
62% of the 157 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.60 vs. ATRI: 1.88 )
ATRI' s 10-Year Yield on cost (5-Year) Range
Min: 1.4   Max: 3.64
Current: 1.88

1.4
3.64
Share Buyback Rate 0.90
ATRI's Share Buyback Rate is ranked higher than
92% of the 221 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: -1.70 vs. ATRI: 0.90 )
ATRI' s 10-Year Share Buyback Rate Range
Min: 12.9   Max: -2.4
Current: 0.9

Valuation & Return

vs
industry
vs
history
Price/Net Cash 326.80
ATRI's Price/Net Cash is ranked higher than
80% of the 341 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 0.00 vs. ATRI: 326.80 )
ATRI' s 10-Year Price/Net Cash Range
Min: 2.11   Max: 340.01
Current: 326.8

2.11
340.01
Price/Net Current Asset Value 21.80
ATRI's Price/Net Current Asset Value is ranked higher than
79% of the 341 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 0.00 vs. ATRI: 21.80 )
ATRI' s 10-Year Price/Net Current Asset Value Range
Min: 1.58   Max: 25.16
Current: 21.8

1.58
25.16
Price/Tangible Book 4.50
ATRI's Price/Tangible Book is ranked higher than
73% of the 341 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 8.90 vs. ATRI: 4.50 )
ATRI' s 10-Year Price/Tangible Book Range
Min: 0.67   Max: 4.65
Current: 4.5

0.67
4.65
Price/DCF (Projected) 1.70
ATRI's Price/DCF (Projected) is ranked higher than
85% of the 341 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 7.24 vs. ATRI: 1.70 )
ATRI' s 10-Year Price/DCF (Projected) Range
Min: 0.84   Max: 13.74
Current: 1.7

0.84
13.74
Price/Median PS Value 1.60
ATRI's Price/Median PS Value is ranked higher than
57% of the 341 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.34 vs. ATRI: 1.60 )
ATRI' s 10-Year Price/Median PS Value Range
Min: 0.2   Max: 1.71
Current: 1.6

0.2
1.71
Price/Peter Lynch Fair Value 3.60
ATRI's Price/Peter Lynch Fair Value is ranked higher than
88% of the 341 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 0.00 vs. ATRI: 3.60 )
ATRI' s 10-Year Price/Peter Lynch Fair Value Range
Min: 0.41   Max: 3.72
Current: 3.6

0.41
3.72
Price/Graham Number 2.10
ATRI's Price/Graham Number is ranked higher than
89% of the 341 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 0.00 vs. ATRI: 2.10 )
ATRI' s 10-Year Price/Graham Number Range
Min: 0.34   Max: 2.46
Current: 2.1

0.34
2.46
Earnings Yield (Greenblatt) 6.90
ATRI's Earnings Yield (Greenblatt) is ranked higher than
92% of the 306 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 3.40 vs. ATRI: 6.90 )
ATRI' s 10-Year Earnings Yield (Greenblatt) Range
Min: 6.2   Max: 21.6
Current: 6.9

6.2
21.6
Forward Rate of Return (Yacktman) 9.84
ATRI's Forward Rate of Return (Yacktman) is ranked higher than
75% of the 159 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 10.90 vs. ATRI: 9.84 )
ATRI' s 10-Year Forward Rate of Return (Yacktman) Range
Min: -16.8   Max: 73.9
Current: 9.84

-16.8
73.9

Business Description

Industry: Medical Instruments & Equipment » Medical Instruments & Supplies
Compare:WST, BAX, COV, TMO, COO » details
Atrion Corp is incorporated in Delaware. The Company and its subsidiaries develop and manufacture products, mainly for medical applications. Its medical products include fluid delivery devices to ophthalmic and cardiovascular products. Its fluid delivery products include proprietary valves that promote infection control and needle safety. It has developed a variety of luer syringe check valves and one-way valves designed to fill, hold and release controlled amounts of fluids or gasses on demand for use in various intubation, catheter and other applications. It also makes tubing clamps in a variety of materials and colors that are compatible with various grades of tubing and sterilization processes, and produce specialized intravenous sets for use in numerous applications including anesthesia and oncology. Its cardiovascular products include MPS2 Myocardial Protection System, or MPS2, a proprietary technology that delivers essential fluids and medications to the heart during open-heart surgery. The MPS2 integrates key functions relating to the delivery of solutions to the heart, such as varying the rate and ratio of oxygenated blood, crystalloid, potassium and other additives, and controlling temperature, pressure and other variables to allow simpler, more flexible management of this process, indicating improved patient outcomes. The MPS2 is the only device used in open-heart surgery that allows for the mixing of drugs into the bloodstream without diluting the blood. The MPS2 employs advanced pump, temperature control and microprocessor technologies and includes a line of disposable products. It also develop and manufacture other cardiovascular products such as cardiac surgery vacuum relief valves; silicone vessel loops for retracting and occluding vessels in minimally invasive surgical procedures; inflation devices for balloon catheter dilation, stent deployment and fluid dispensing; as well as products used in heart bypass surgery to make a precision opening in the heart for attachment of the bypass vessels. The Company is a manufacturer of contact lens disinfection cases. It also manufacture a proprietary line of balloon catheters used in the treatment of nasolacrimal duct obstruction in children and adults. Nasolacrimal duct obstruction can cause a condition called epiphora, or chronic tearing. People affected by this condition experience excessive and uncontrollable tearing and often encounter infection as a result of nasolacrimal blockage. In addition, it manufactures and sells a line of products designed for safe needle and scalpel blade containment. It is also the manufacturer of inflation systems and valves used in marine and aviation safety products. It manufactures inflation systems and valves for products such as life vests, life rafts, inflatable boats, survival equipment, and other inflatable structures. It also produce one-way and two-way pressure relief valves for use on electronics cases, munitions cases, pressure
» More Articles for ATRI

Headlines

Articles On GuruFocus.com
Atrion Corporation Declares Quarterly Cash Dividend Nov 14 2014 
3 Cheap Health Care Dividend Stocks with Huge Potential to Grow Dividends Oct 02 2013 
Billionaires Hold Three Undervalued, Predictable Stocks with Yield Sep 16 2013 
26 Stocks Raised Dividends Over the Past Week Aug 18 2013 
My 4 Favorite Dividend Contenders with Highest Dividend Growth Potential May 24 2013 
Atrion Corporation: Track Record of Delivery Dec 03 2012 
comment on ATRI Oct 06 2012 
How to Look Beyond Dividend Increases Aug 27 2012 
medical buffett lett Jun 17 2012 
131 Feb 22 2012 

More From Other Websites
ATRION CORP Financials Mar 19 2015
ATRION CORP Files SEC form 10-K, Annual Report Mar 13 2015
Atrion Corporation Declares Quarterly Cash Dividend Mar 03 2015
Atrion Corporation Declares Quarterly Cash Dividend Mar 03 2015
Atrion Reports Fourth Quarter and Full Year 2014 Results Feb 24 2015
ATRION CORP Files SEC form 8-K, Results of Operations and Financial Condition Feb 23 2015
Atrion Reports Fourth Quarter and Full Year 2014 Results Feb 23 2015
Atrion Corporation Declares Quarterly Cash Dividend Nov 14 2014
Atrion Reports Third Quarter Results Oct 31 2014
ATRION CORP Files SEC form 8-K, Results of Operations and Financial Condition Oct 31 2014
Atrion Reports Third Quarter Results Oct 31 2014
Atrion Corporation Increases Quarterly Cash Dividend by 17% Sep 03 2014
ATRION CORP Files SEC form 8-K, Results of Operations and Financial Condition Aug 06 2014
Atrion Reports Second Quarter Results Aug 06 2014
ATRION CORP Files SEC form 8-K, Submission of Matters to a Vote of Security Holders May 23 2014
Atrion Corporation Declares Quarterly Cash Dividend May 22 2014
ATRION CORP Files SEC form 8-K, Results of Operations and Financial Condition May 05 2014
Atrion Reports First Quarter Results May 05 2014

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK